Cat: IPD-X26675

Recombinant Human Ataxin-3 Protein,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • 基因名

    Ataxin-3

  • 简介

    Ataxin-3 is a deubiquitinating enzyme that maintains proteostasis, regulates transcription, and is involved in cytoskeletal dynamics, myogenesis, and degradation of misfolded chaperone substrates. It trims long polyubiquitin chains and interacts with STUB1/CHIP to limit ubiquitin chain length, preventing further elongation. Ataxin-3 Protein, Human (His) is the recombinant human-derived Ataxin-3 protein, expressed by E. coli , with N-6*His labeled tag.

  • Application

    SPRMSTBLIITCELISA细胞实验药物筛选

  • 生物活性

    Measured in a cell proliferation assay using SH-SY5Y human neuroblastoma cells. The ED50 this effect is 2.979 ng/ml, corresponding to a specific activity is 3.36×105 units/mg. Measured in a cell proliferation assay using SH-SY5Y human neuroblastoma cells. The ED50 for this effect is 2.979 ng/ml, corresponding to a specific activity is 3.36×105 units/mg.

  • 别名

    Ataxin-3; ATXN3; Machado-Joseph disease protein 1; Spinocerebellar ataxia type 3 protein; ATX3, MJD, MJD1; SCA3

  • 种属

    Human

  • 表达系统

    E. coli

  • 标签

    N-6*His

  • 纯度

    Greater than 95% as determined by SDS-PAGE.

  • 蛋白编号

    P54252-2

  • 表达区间

    M1-K361

  • 氨基酸序列

    MESIFHEKQEGSLCAQHCLNNLLQGEYFSPVELSSIAHQLDEEERMRMAEGGVTSEDYRTFLQQPSGNMDDSGFFSIQVISNALKVWGLELILFNSPEYQRLRIDPINERSFICNYKEHWFTVRKLGKQWFNLNSLLTGPELISDTYLALFLAQLQQEGYSIFVVKGDLPDCEADQLLQMIRVQQMHRPKLIGEELAQLKEQRVHKTDLERVLEANDGSGMLDEDEEDLQRALALSRQEIDMEDEEADLRRAIQLSMQGSSRNISQDMTQTSGTNLTSEELRKRREAYFEKQQQKQQQQQQQQQQGDLSGQSSHPCERPATSSGALGSDLGDAMSEEDMLQAAVTMSLETVRNDLKTEGKK

  • 蛋白长度

    Full Length of Isoform-2

  • 分子量

    43 kDa

  • 内毒素

    < 1.0 EU per μg protein as determined by the LAL method.

  • 性状

    Freeze-dried powder

  • 缓冲液

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • 复溶方法

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • 个性化定制

    点位突变 标签定制 buffer定制 全长蛋白定制

  • 稳定性测试

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • 保存条件 & 期限

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • 运输条件

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

Ataxin-3 is a polyglutamine (polyQ) protein associated with Machado-Joseph disease (MJD), a neurodegenerative disorder characterized by motor dysfunction, ataxia, and cognitive decline. The gene responsible for MJD, ATXN3, encodes the ataxin-3 protein, which contains a variable number of glutamine repeats. The pathogenesis of MJD is linked to the expansion of these repeats, leading to the misfolding and accumulation of ataxin-3, which disrupts cellular functions. The study of recombinant ataxin-3 proteins has become essential for understanding the molecular mechanisms underlying MJD. These recombinant proteins allow researchers to investigate the structure-function relationships of ataxin-3, particularly how polyQ expansion affects its interactions with other cellular partners and its role in cellular processes such as ubiquitin-proteasome system function and autophagy. Additionally, recombinant ataxin-3 is used to develop potential therapeutic strategies, including small molecules and gene therapy approaches, aimed at modulating its aggregation and restoring normal cellular functions. Overall, this research offers crucial insights into the disease mechanisms and potential avenues for intervention in MJD and related disorders.

客服热线

027-8586 6806

E-mail

sales@ipodix.cn

人工客服①

汪经理

18007124176


加微信咨询

人工客服②

简经理

18164034885


加微信咨询
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
  • 30000+

    Recombinant

  • 100+

    Researcher

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US